SLNOLawsuits•prnewswire•
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman
Sentiment:Negative (-70)
Summary
SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by Scorpion Capital. Hagens Berman, a national shareholders rights firm, has opened an...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 20, 2025 by prnewswire